Medical devices, healthcare technology and the business of care
510(k) clearance · K253875

OxyPure (olifilcon A) Spherical Biweekly Silicone Hydrogel Soft Contact Lens; OxyPure (olifilcon A) Toric Biweekly Silicone Hydrogel Soft Contact Lens; OxyPure (olifilcon A) Multifocal Biweekly Silicone Hydrogel Soft Contact Lens

Visco Vision, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK253875

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-23 for K253875, a traditional 510(k) from Visco Vision, Inc. of Taoyuan City, TW. The device is listed as OxyPure (olifilcon A) biweekly silicone hydrogel soft contact lenses in spherical, toric and multifocal designs, classified as Lenses, Soft Contact, Daily Wear under 21 CFR 886.5925, product code LPL with subsequent product code MVN, in the Ophthalmic specialty. The application was received 12/04/2025 and was not reviewed by a third party.

SESE means FDA cleared the submission as substantially equivalent to a predicate device; it is not PMA approval. The record does not identify the predicate device, the specific tests or clinical data supporting equivalence, or any labeling conditions, so the basis for the equivalence finding remains unknown from this source. No summary statement is attached to the record, and the page shows no combination product or predetermined change control plan.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Oct 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253875
Regulatory pathway
510(k) premarket notification
Product code
LPL
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lenses, Soft Contact, Daily Wear.

Product code
LPL
FDA device class
2

FDA decision timeline

  1. K253875 received

    Application receipt date recorded by FDA.

  2. K253875 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LPL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Visco Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Taoyuan City

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records